Lifeboat Foundation

https://www.forbes.com/sites/forbestechcouncil/2020/01/23/ar…ngularity/

[*This article was first published in the September 2017 issue of Paradigm Explorer: The Journal of the Scientific and Medical Network (Established 1973). The article was drawn from the author’s original work in her book: The Future: A Very Short Introduction (Oxford University Press, 2017), especially from Chapters 4 & 5.]

We are at a critical point today in research into human futures. Two divergent streams show up in the human futures conversations. Which direction we choose will also decide the fate of earth futures in the sense of Earth’s dual role as home for humans, and habitat for life. I choose to deliberately oversimplify here to make a vital point.

The two approaches I discuss here are informed by Oliver Markley and Willis Harman’s two contrasting future images of human development: ‘evolutionary transformational’ and ‘technological extrapolationist’ in Changing Images of Man (Markley & Harman, 1982). This has historical precedents in two types of utopian human futures distinguished by Fred Polak in The Image of the Future (Polak, 1973) and C. P. Snow’s ‘Two Cultures’ (the humanities and the sciences) (Snow, 1959).

What I call ‘human-centred futures’ is humanitarian, philosophical, and ecological. It is based on a view of humans as kind, fair, consciously evolving, peaceful agents of change with a responsibility to maintain the ecological balance between humans, Earth, and cosmos. This is an active path of conscious evolution involving ongoing psychological, socio-cultural, aesthetic, and spiritual development, and a commitment to the betterment of earthly conditions for all humanity through education, cultural diversity, greater economic and resource parity, and respect for future generations.

Continue reading “Contrasting Human Futures: Technotopian or Human-Centred?*” »

This film was compiled from audio of a discussion futurist FM-2030 held at the University of California on February 6th, 1994. In this discussion 2030 laid out an overview of his ‘transhuman’ philosophy and held a back and forth with other people present in the discussion. Discussion and debate included items such as the value of researching ‘indefinite lifespan’ technologies directly as opposed to (or in addition to) more traditional approaches, such as researching cures for specific diseases.
The excerpts in this archive file present a sort of thesis of FM 2030’s transhuman ideas.

About FM 2030: FM 2030 was at various points in his life, an Iranian Olympic basketball player, a diplomat, a university teacher, and a corporate consultant. He developed his views on transhumanism in the 1960s and evolved them over the next thirty-something years. He was placed in cryonic suspension July 8th, 2000. For more information about FM 2030, view the GPA Archive File: ‘Introduction to FM 2030′ or visit some of the following links:

Continue reading “FM-2030: Are You Transhuman?” »

Superlubricity nano-structured self-assembling coating repairs surface wear, decreases emissions and increases HP and gas mileage.

Globally about 15 percent of manmade carbon dioxide comes from vehicles. In more developed countries, cars, trucks, airplanes, ships and other vehicles account for a third of emissions related to climate change. Emissions standards are fueling the lubricant additives market with innovation.

Up to 33% of fuel energy in vehicles is used to overcome friction. Tribology is the science of interacting surfaces in relative motion inclusive of friction, wear and lubrication. This is where TriboTEX, a nanotechnology startup is changing the game of friction modification and wear resilience with a lubricant additive that forms a nano-structured coating on metal alloys.

This nano-structured coating increases operating efficiency and component longevity. It is comprised of synthetic magnesium silicon hydroxide nanoparticles that self-assemble as an ultralow friction layer, 1/10 of the original friction resistance. The coating is self-repairing during operation, environmentally inert and extracts carbon from the oil. The carbon diamond-like nano-particle lowers the friction budget of the motor, improving fuel economy and emissions in parallel while increasing the power and longevity of the motor.

TriboTEX has a Kickstarter campaign that has just surpassed $100,000 in funding. The early bird round has just closed that offered the product at one half the cost of its retail. The final round offers the lubricant system self-forming coating at 75 percent and is ending shortly. The founder Dr. Pavlo Rudenko, Ph.D. is a graduate of Singularity University GSP11 program.

Fox 29 — Good Day Philadelphia

http://www.fox29.com/140735577-video

NBC TV 10

Continue reading “Bringing The Dead Back To Life — Reanima Project / Bioquark Inc. Media Coverage” »

Bioquark, Inc., (http://www.bioquark.com) a company focused on the development of novel biologics for complex regeneration and disease reversion, and Revita Life Sciences, (http://revitalife.co.in) a biotechnology company focused on translational therapeutic applications of autologous stem cells, have announced that they have received IRB approval for a study focusing on a novel combinatorial approach to clinical intervention in the state of brain death in humans.

This first trial, within the portfolio of Bioquark’s Reanima Project (http://www.reanima.tech) is entitled “Non-randomized, Open-labeled, Interventional, Single Group, Proof of Concept Study With Multi-modality Approach in Cases of Brain Death Due to Traumatic Brain Injury Having Diffuse Axonal Injury” (https://clinicaltrials.gov/ct2/show/NCT02742857?term=bioquark&rank=1), will enroll an initial 20 subjects, and be conducted at Anupam Hospital in Rudrapur, Uttarakhand India.

Continue reading “Bioquark Inc. and Revita Life Sciences Receive IRB Approval for First-In-Human Brain Death Study” »

I have spent the last 30 years in various aspects of the biopharmaceutical industry, which for the most part has been a very rewarding experience.

However, during this time period, having been immersed many different components of therapeutic development and commercialization, one thing has always bothered me: a wide array of promising research never makes it off the bench to see the translational light of day, and gets lost in the historical scientific archives.

I always believed that scientific progress happened in a very linear narrative, with each new discovery supporting the next, resulting ultimately in an eventual stairway of scientific enlightenment.

Continue reading “Death Reversal — The Reanima Project — Research Whose Time Has Come” »